Product Information
TEMOZOLOMIDE 140 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $11.4609 per EA under NDC 67877054007. Its NADAC has been published 82 times since Aug 21, 2024.
Strength
140 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877054007
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207658On Market Since
4/28/2017
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 140 MG CAPSULE has been published 82 times since Aug 21, 2024, and over the history we have for it it has risen 74.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4609 per EA |
|---|---|
| All-time high | $12.1860 (Jun 11, 2025) |
| All-time low | $6.5705 (Aug 21, 2024) |
| 52-week high | $11.4609 |
| 52-week low | $11.4609 |
| Median price | $11.4609 |
| Average price | $9.9849 |
| Largest weekly change | +20.6% (Mar 19, 2025) |
| Weeks tracked | 82 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 140 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $11.4609 per EA (NDC 67877054007), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has risen 74.4%. It has been tracked across 82 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 140 MG CAPSULE?
Since Aug 21, 2024, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has ranged from a low of $6.5705 (Aug 21, 2024) to a high of $12.1860 (Jun 11, 2025), with a median of $11.4609 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 140 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 140 MG CAPSULE, is $10.7251 per EA — about 6% below TEMOZOLOMIDE 140 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 140 MG CAPSULE?
TEMOZOLOMIDE 140 MG CAPSULE (NDC 67877054007) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification